嘉華股份(603182.SH):上半年淨利潤5778.68萬元 同比減少6.84%
格隆匯8月14日丨嘉華股份(603182.SH)公佈半年度報吿,今年上半年度,公司實現營業收入7.82億元,較上年同期減少8.62%;實現歸屬於上市公司股東的淨利潤5,778.68萬元,較上年同期減少6.84%;實現歸屬於上市公司股東的扣除非經常性損益的淨利潤5,648.44萬元,較上年同期減少7.26%。
報吿期內,面對主要產品價格持續走低的不利因素,公司從工藝改造、產量提升及能源降耗入手,持續開展生產設備改造及產品工藝優化,調整工藝參數,不斷釋放產能潛力,主要產品產量均實現同比增長,工藝創新與節能降耗並舉,基本完成預定生產目標的同時實現了綜合成本明顯下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.